11-beta-hydroxysteroid dehydrogenase-1 inhibitors (Johnson & Johnson)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Name11-beta-hydroxysteroid dehydrogenase-1 inhibitors (Johnson & Johnson)
Drug Alias Name11-beta-HSD1 inhibitors (Johnson & Johnson)JNJ-16171207JNJ-38445303JNJ-25918646JNJ-31064423
ClassificationSmall molecules
Mechanisms of Action11-beta-hydroxysteroid dehydrogenase inhibitors
Targets11-beta-hydroxysteroid dehydrogenase
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A